loader

World Tenders & Procurement Opportunities

506508- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12)

World Biggest Tenders Source

This tender with title 506508- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12) has been published on Bidding Source portal dated 04 Aug 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

506508- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12)
Invitation for Bids
506508
Germany
4 Aug 2025
30 Sep 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

503606-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and EurimPharm Arzneimittel GmbH for Zepatier(R) Germany 500116-Awarded - Germany – Pharmaceutical products – Open House Pharmaceutical Discount Agreements Announcement of concluded contracts 16.05.2025 - 15.06.2025 Germany 490165- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the aforementioned active ingredients with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 492605- Germany – Pharmaceutical products – Patent_85.2_Lonquex Germany 495360-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Azelastine + Fluticasone, ATC R01AD28 for the period 01.02.2024 - 31.01.2026 Germany 494733-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Milnacipran, ATC N06AX17 (OBG) for the period 01.09.2024 - 31.08.2026 Germany 493347-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient paliperidone (exclusively 1-month depot), ATC N05AX13 for the period 01.01.2024 - 31.12.2025 Germany 492076-Awarded - Germany – Pharmaceutical products – Rabattvertrag nach §130a Abs.8 SGB V Germany 481643- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient ustekinumab Germany 488809- Germany – Pharmaceutical products – Open house drug discount agreements Aripiprazole in the dosage form depot suspension for injection, ATC N05AX12 (copy) Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans